SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
Clinical trial NCT02830542 · COMPLETED
Trial details
- NCT number
- NCT02830542
- Sponsor
- Seres Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2018-05-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.